Ischemic preconditioning via epsilon protein kinase C activation requires cyclooxygenase-2 activation in vitro

Neuroscience

Volumn 145, Issue 3, 2007, Pages 931-941

  Kim, E ^a   Raval, A P ^a   DeFazio, R A ^a   Perez Pinzon, M A ^a  

^a Neuroscience Program ^*  (United States)

Author keywords

ERK1 2; ischemia; mixed cortical neuron astrocyte cell cultures; neuroprotection; organotypic hippocampal slice cultures; oxygen glucose deprivation

Indexed keywords

CYCLOOXYGENASE 2; GLUCOSE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; OXYGEN; PROTEIN KINASE C EPSILON;

ANIMAL CELL; ARTICLE; ASTROCYTE; BRAIN CELL; BRAIN SLICE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INDUCTION; HIPPOCAMPUS; IN VITRO STUDY; ISCHEMIC PRECONDITIONING; NERVE CELL CULTURE; NEUROPROTECTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ASTROCYTES; CELL CULTURE TECHNIQUES; CELL DEATH; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; ENZYME ACTIVATION; HIPPOCAMPUS; ISCHEMIC PRECONDITIONING; KINETICS; L-LACTATE DEHYDROGENASE; MALE; N-METHYLASPARTATE; NEURONS; ORGAN CULTURE TECHNIQUES; PROTEIN KINASE C-EPSILON; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION;

EID: 33947325960     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.12.063     Document Type: Article

References (53)

1. Adderley S.R., and Fitzgerald D.J. Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1/2-mediated induction of cyclooxygenase-2. J Biol Chem 274 (1999) 5038-5046
2. Allport V.C., Slater D.M., Newton R., and Bennett P.R. NF-kappaB and AP-1 are required for cyclo-oxygenase 2 gene expression in amnion epithelial cell line (WISH). Mol Hum Reprod 6 (2000) 561-565
3. Baik E.J., Kim E.J., Lee S.H., and Moon C. Cyclooxygenase-2 selective inhibitors aggravate kainic acid induced seizure and neuronal cell death in the hippocampus. Brain Res 843 (1999) 118-129
4. Bazan N.G., Fletcher B.S., Herschman H.R., and Mukherjee P.K. Platelet-activating factor and retinoic acid synergistically activate the inducible prostaglandin synthase gene. Proc Natl Acad Sci U S A 91 (1994) 5252-5256
5. Blanco A., Habib A., Levy-Toledano S., and Maclouf J. Involvement of tyrosine kinases in the induction of cyclo-oxygenase-2 in human endothelial cells. Biochem J 312 Pt 2 (1995) 419-423
6. Blondeau N., Widmann C., Lazdunski M., and Heurteaux C. Activation of the nuclear factor-kappaB is a key event in brain tolerance. J Neurosci 21 (2001) 4668-4677
7. Bolli R. The late phase of preconditioning. Circ Res 87 (2000) 972-983
8. Bolli R., Dawn B., Tang X.L., Qiu Y., Ping P., Xuan Y.T., Jones W.K., Takano H., Guo Y., and Zhang J. The nitric oxide hypothesis of late preconditioning. Basic Res Cardiol 93 (1998) 325-338
9. Chen L.C., Chen B.K., and Chang W.C. Activating protein 1-mediated cyclooxygenase-2 expression is independent of N-terminal phosphorylation of c-Jun. Mol Pharmacol 67 (2005) 2057-2069
10. Dawn B., and Bolli R. Role of nitric oxide in myocardial preconditioning. Ann N Y Acad Sci 962 (2002) 18-41
11. Di-Capua N., Sperling O., and Zoref-Shani E. Protein kinase C-epsilon is involved in the adenosine-activated signal transduction pathway conferring protection against ischemia-reperfusion injury in primary rat neuronal cultures. J Neurochem 84 (2003) 409-412
12. Digicaylioglu M., and Lipton S.A. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 412 (2001) 641-647
13. Fan X.M., Wong B.C., Lin M.C., Cho C.H., Wang W.P., Kung H.F., and Lam S.K. Interleukin-1beta induces cyclo-oxygenase-2 expression in gastric cancer cells by the p38 and p44/42 mitogen-activated protein kinase signaling pathways. J Gastroenterol Hepatol 16 (2001) 1098-1104
14. Gendron T.F., Brunette E., Tauskela J.S., and Morley P. The dual role of prostaglandin E(2) in excitotoxicity and preconditioning-induced neuroprotection. Eur J Pharmacol 517 (2005) 17-27
15. Gilroy D.W., Colville-Nash P.R., Willis D., Chivers J., Paul-Clark M.J., and Willoughby D.A. Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med 5 (1999) 698-701
16. Gonzalez-Zulueta M., Feldman A.B., Klesse L.J., Kalb R.G., Dillman J.F., Parada L.F., Dawson T.M., and Dawson V.L. Requirement for nitric oxide activation of p21(ras)/extracellular regulated kinase in neuronal ischemic preconditioning. Proc Natl Acad Sci U S A 97 (2000) 436-441
17. Horiguchi T., Snipes J.A., Kis B., Shimizu K., and Busija D.W. The role of nitric oxide in the development of cortical spreading depression-induced tolerance to transient focal cerebral ischemia in rats. Brain Res 1039 (2005) 84-89
18. Horiguchi T., Snipes J.A., Kis H.B., Shimizu K., and Busija D.W. Cyclooxygenase-2 mediates the development of cortical spreading depression-induced tolerance to transient focal cerebral ischemia in rats. Neuroscience 140 (2006) 723-730
19. Hoshida S., Kuzuya T., Fuji H., Yamashita N., Oe H., Hori M., Suzuki K., Taniguchi N., and Tada M. Sublethal ischemia alters myocardial antioxidant activity in canine heart. Am J Physiol 264 (1993) H33-H39
20. Iadecola C., and Gorelick P.B. The Janus face of cyclooxygenase-2 in ischemic stroke: shifting toward downstream targets. Stroke 36 (2005) 182-185
21. Jung Y.J., Isaacs J.S., Lee S., Trepel J., and Neckers L. IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J 17 (2003) 2115-2117
22. Kawano T., Anrather J., Zhou P., Park L., Wang G., Frys K.A., Kunz A., Cho S., Orio M., and Iadecola C. Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity. Nat Med 12 (2006) 225-229
23. Kim E.J., Kwon K.J., Park J.Y., Lee S.H., Moon C.H., and Baik E.J. Effects of peroxisome proliferator-activated receptor agonists on LPS-induced neuronal death in mixed cortical neurons: associated with iNOS and COX-2. Brain Res 941 (2002) 1-10
24. Kim E.J., Kwon K.J., Park J.Y., Lee S.H., Moon C.H., and Baik E.J. Neuroprotective effects of prostaglandin E2 or cAMP against microglial and neuronal free radical mediated toxicity associated with inflammation. J Neurosci Res 70 (2002) 97-107
25. Kim E.J., Lee J.E., Kwon K.J., Lee S.H., Moon C.H., and Baik E.J. Differential roles of cyclooxygenase isoforms after kainic acid-induced prostaglandin E(2) production and neurodegeneration in cortical and hippocampal cell cultures. Brain Res 908 (2001) 1-9
26. Kim S.J., and Chun J.S. Protein kinase C alpha and zeta regulate nitric oxide-induced NF-kappa B activation that mediates cyclooxygenase-2 expression and apoptosis but not dedifferentiation in articular chondrocytes. Biochem Biophys Res Commun 303 (2003) 206-211
27. Koh J.Y., and Choi D.W. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J Neurosci Methods 20 (1987) 83-90
28. Lange-Asschenfeldt C., Raval A.P., Dave K.R., Mochly-Rosen D., Sick T.J., and Perez-Pinzon M.A. Epsilon protein kinase C mediated ischemic tolerance requires activation of the extracellular regulated kinase pathway in the organotypic hippocampal slice. J Cereb Blood Flow Metab 24 (2004) 636-645
29. LaPointe M.C., Mendez M., Leung A., Tao Z., and Yang X.P. Inhibition of cyclooxygenase-2 improves cardiac function after myocardial infarction in the mouse. Am J Physiol Heart Circ Physiol 286 (2004) H1416-H1424
30. Li R.C., Ping P., Zhang J., Wead W.B., Cao X., Gao J., Zheng Y., Huang S., Han J., and Bolli R. PKCepsilon modulates NF-kappaB and AP-1 via mitogen-activated protein kinases in adult rabbit cardiomyocytes. Am J Physiol Heart Circ Physiol 279 (2000) H1679-H1689
31. Lin T.N., Cheung W.M., Wu J.S., Chen J.J., Lin H., Liou J.Y., Shyue S.K., and Wu K.K. 15d-Prostaglandin J2 protects brain from ischemia-reperfusion injury. Arterioscler Thromb Vasc Biol 26 (2006) 481-487
32. Ludwig L.M., Weihrauch D., Kersten J.R., Pagel P.S., and Warltier D.C. Protein kinase C translocation and Src protein tyrosine kinase activation mediate isoflurane-induced preconditioning in vivo: potential downstream targets of mitochondrial adenosine triphosphate-sensitive potassium channels and reactive oxygen species. Anesthesiology 100 (2004) 532-539
33. Lukiw W.J., and Bazan N.G. Strong nuclear factor-kappaB-DNA binding parallels cyclooxygenase-2 gene transcription in aging and in sporadic Alzheimer's disease superior temporal lobe neocortex. J Neurosci Res 53 (1998) 583-592
34. McAdam B.F., Catella-Lawson F., Mardini I.A., Kapoor S., Lawson J.A., and FitzGerald G.A. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. Proc Natl Acad Sci U S A 96 (1999) 272-277
35. McCullough L., Wu L., Haughey N., Liang X., Hand T., Wang Q., Breyer R.M., and Andreasson K. Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia. J Neurosci 24 (2004) 257-268
36. Minghetti L. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol 63 (2004) 901-910
37. Nakayama M., Uchimura K., Zhu R.L., Nagayama T., Rose M.E., Stetler R.A., Isakson P.C., Chen J., and Graham S.H. Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia. Proc Natl Acad Sci U S A 95 (1998) 10954-10959
38. Raval A.P., Dave K.R., Mochly-Rosen D., Sick T.J., and Perez-Pinzon M.A. Epsilon PKC is required for the induction of tolerance by ischemic and NMDA-mediated preconditioning in the organotypic hippocampal slice. J Neurosci 23 (2003) 384-391
39. Rodriguez J.A., De la Cerda P., Collyer E., Decap V., Vio C.P., and Velarde V. Cyclooxygenase-2 induction by bradykinin in aortic vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 290 (2006) H30-H36
40. Sasaki T., Kitagawa K., Yamagata K., Takemiya T., Tanaka S., Omura-Matsuoka E., Sugiura S., Matsumoto M., and Hori M. Amelioration of hippocampal neuronal damage after transient forebrain ischemia in cyclooxygenase-2-deficient mice. J Cereb Blood Flow Metab 24 (2004) 107-113
41. Shinmura K., Bolli R., Liu S.Q., Tang X.L., Kodani E., Xuan Y.T., Srivastava S., and Bhatnagar A. Aldose reductase is an obligatory mediator of the late phase of ischemic preconditioning. Circ Res 91 (2002) 240-246
42. Shinmura K., Xuan Y.T., Tang X.L., Kodani E., Han H., Zhu Y., and Bolli R. Inducible nitric oxide synthase modulates cyclooxygenase-2 activity in the heart of conscious rabbits during the late phase of ischemic preconditioning. Circ Res 90 (2002) 602-608
43. Shinmura K., Tang X.L., Wang Y., Xuan Y.T., Liu S.Q., Takano H., Bhatnagar A., and Bolli R. Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits. Proc Natl Acad Sci U S A 97 (2000) 10197-10202
44. Smith W.L., Garavito R.M., and DeWitt D.L. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 271 (1996) 33157-33160
45. Takeda K., Lin J., Okubo S., Akazawa-Kudoh S., Kajinami K., Kanemitsu S., Tsugawa H., Kanda T., Matsui S., and Takekoshi N. Transient glucose deprivation causes upregulation of heme oxygenase-1 and cyclooxygenase-2 expression in cardiac fibroblasts. J Mol Cell Cardiol 36 (2004) 821-830
46. von Knethen A., Callsen D., and Brune B. Superoxide attenuates macrophage apoptosis by NF-kappa B and AP-1 activation that promotes cyclooxygenase-2 expression. J Immunol 163 (1999) 2858-2866
47. Weber N.C., Toma O., Wolter J.I., Obal D., Mullenheim J., Preckel B., and Schlack W. The noble gas xenon induces pharmacological preconditioning in the rat heart in vivo via induction of PKC-epsilon and p38 MAPK. Br J Pharmacol 144 (2005) 123-132
48. Wu H.H., Hsieh W.S., Yang Y.Y., and Tsai M.C. Lipoteichoic acid induces prostaglandin E(2) release and cyclooxygenase-2 synthesis in rat cortical neuronal cells: involvement of PKCepsilon and ERK activation. Life Sci 79 (2006) 272-280
49. Xu G.P., Dave K.R., Vivero R., Schmidt-Kastner R., Sick T.J., and Perez-Pinzon M.A. Improvement in neuronal survival after ischemic preconditioning in hippocampal slice cultures. Brain Res 952 (2002) 153-158
50. Xuan Y.T., Guo Y., Zhu Y., Wang O.L., Rokosh G., Messing R.O., and Bolli R. Role of the protein kinase C-epsilon-Raf-1-MEK-1/2-p44/42 MAPK signaling cascade in the activation of signal transducers and activators of transcription 1 and 3 and induction of cyclooxygenase-2 after ischemic preconditioning. Circulation 112 (2005) 1971-1978
51. Xuan Y.T., Tang X.L., Banerjee S., Takano H., Li R.C., Han H., Qiu Y., Li J.J., and Bolli R. Nuclear factor-kappaB plays an essential role in the late phase of ischemic preconditioning in conscious rabbits. Circ Res 84 (1999) 1095-1109
52. Yasojima K., Schwab C., McGeer E.G., and McGeer P.L. Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs. Brain Res 830 (1999) 226-236
53. Zhao T.C., and Kukreja R.C. Late preconditioning elicited by activation of adenosine A(3) receptor in heart: role of NF- kappa B, iNOS and mitochondrial K(ATP) channel. J Mol Cell Cardiol 34 (2002) 263-277